Rapid-onset diabetic nephropathy in type II diabetes mellitus.
We report a case of rapidly progressive diabetic nephropathy, from little diabetic change on renal biopsy to severe, nodular, diabetic nephrosclerosis over 32 months. The patient was taking an angiotensin converting enzyme inhibitor and had a mean arterial pressure of 95 mm Hg over this time period. Her dietary protein intake was low, at least upon presentation. She had three additional mechanisms or potential mechanisms of injury: monoclonal kappa light chains; IgA immune deposits on the first, but not the second biopsy; and longstanding hypertension. Her renal histology was typical for diabetic nephropathy but was not characteristic of kappa light chain disease. We suggest that diabetic nephropathy may develop more rapidly than previously assumed, especially when additional mechanisms of injury, or additional promoters of mesangial matrix accumulation are present.
Dillon
J J
JJ
Department of Medicine, University of Chicago Pritzker School of Medicine, Illinois, USA.
Sedmak
D D
DD
Cosio
F G
FG
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000473:pathology / Q000503:physiopathology*; D018753:Diet, Protein-Restricted; D005260:Female; D005920:Glomerular Mesangium / Q000648:ultrastructure; D006801:Humans; D006973:Hypertension / Q000150:complications; D007070:Immunoglobulin A / Q000032:analysis; D007145:Immunoglobulin kappa-Chains / Q000276:immunology; D009400:Nephrosclerosis / Q000209:etiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000911:Antibodies, Monoclonal; D007070:Immunoglobulin A; D007145:Immunoglobulin kappa-Chains